Showing results (841-850 of 3,350) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|July 28, 2017
Replicating Health Economic Models: Firm Foundations or a House of Cards?Inigo Bermejo, Paul Tappenden, Ji-Hee YounPharmacoeconomics|March 27, 2016
The Effects of Diagnostic Definitions in Claims Data on Healthcare Cost Estimates: Evidence from a Large-Scale Panel Data Analysis of Diabetes Care in JapanHaruhisa Fukuda, Shunya Ikeda, Takeru Shiroiwa, et al.Pharmacoeconomics|March 18, 2016
A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug ReactionsCatrin O Plumpton, Daniel Roberts, Munir Pirmohamed, et al.Pharmacoeconomics|February 23, 2016
Systematic Review of Model-Based Economic Evaluations of Treatments for Alzheimer's DiseaseLuis Hernandez, Asli Ozen, Rodrigo DosSantos, et al.Pharmacoeconomics|February 18, 2016
Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in FranceSylvain Druais, Agathe Doutriaux, Magali Cognet, et al.Pharmacoeconomics|February 20, 2016
Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?Milad Karimi, John BrazierPharmacoeconomics|December 15, 2015
Understanding Adherence and Prescription Patterns Using Large-Scale Claims DataMargrét V Bjarnadóttir, Sana Malik, Eberechukwu Onukwugha, et al.Pharmacoeconomics|October 21, 2017
Estimating Health State Utility Values for ComorbiditiesRoberta Ara, John BrazierPharmacoeconomics|October 21, 2017
The Use of Mapping to Estimate Health State Utility ValuesRoberta Ara, Donna Rowen, Clara MukuriaPharmacoeconomics|October 21, 2017
The Use of Health State Utility Values in Decision ModelsRoberta Ara, John Brazier, Ismail Azzabi ZouraqPageof 335